两种方式:STAT3缺乏如何阻止移植与宿主疾病,同时保持移植与白血病活动
The Journal of clinical investigation
|August 1, 2023
概括
研究人员发现了一种通过修改T细胞来增强白血病治疗的方法. 这种方法将有益的抗白血病效应与有害的移植对宿主疾病分离开来,改善异构造血细胞移植患者的治疗结果.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 全基性造血细胞移植 (HCT) 通过移植对抗白血病 (GVL) 效应为高风险白血病提供治疗方法.
- 移植与宿主疾病 (GVHD) 构成了重大挑战,导致炎症和器官损伤,限制了HCT的疗效.
- 由于GVHD,感染和白血病复发风险,HCT仍然是一种有毒疗法.
研究的目的:
- 研究将GVL效应与GVHD分离的方法.
- 探索T细胞Stat3缺陷在HCT后调节免疫反应中的作用.
- 了解底层组织特异性免疫细胞活动的机制.
主要方法:
- 使用了一种异构HCT的小鼠模型.
- 基因改造的供体T细胞缺乏Stat3表达.
- 分析了T细胞的生物能量和各种器官中的功能.
- 评估了GVL活动和GVHD严重程度.
主要成果:
- T细胞Stat3缺陷成功地将GVL从GVHD分离出来.
- 这种分离是通过编程死亡连接1/编程细胞死亡蛋白1 (PD-L1/PD-1) 依赖途径进行的.
- 在淋巴血液构成组织中保持了有益的抗白血病活性.
- 在GVHD目标器官中有害的T细胞效应被削弱.
结论:
- T细胞Stat3缺乏症代表了一种新的策略,可以在保持GVL的同时减轻GVHD.
- PD-L1/PD-1-依赖的生物能变化是这种解离的关键.
- 这一发现可能会为白血病患者带来更安全,更有效的全源性高血压试验.
相关概念视频
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K
Cell-mediated Immune Responses
68.9K
Overview
68.9K
Bone Marrow Sampling and Transplants
360
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
360
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K


